Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Element Biosciences Names Danae Van Oene as SVP of Global Sales & Support | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Element Biosciences Names Danae Van Oene as SVP of Global Sales & Support

Van Oene will spearhead Element's commercial sales initiatives, overseeing regions worldwide.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Element Biosciences, Inc. has appointed Danae Van Oene as Senior Vice President of Global Sales and Support.
 
In her new role, Van Oene will spearhead Element’s commercial sales initiatives, overseeing regions including North America, Asia Pacific, EMEA, Latin America and others worldwide. As Element expands its global customer base, she will work with Element customers and distributors internationally to maximize operational excellence and translate feedback into product innovations.

Experience

Van Oene was most recently 10x Genomics’ Vice President and General Manager for the Americas region after previously leading its global sales programs, global distribution, and strategic partnerships. Before joining 10x Genomics, she held global sales management roles at Illumina and was Distribution Territory Manager for Beckman Coulter.
 
“Danae will play an instrumental role in expanding our global presence and strengthening relationships with our customers and distributors across the world,” said Molly He, PhD, CEO and co-founder of Element Biosciences. “Danae’s expertise and proven track record of success will help Element advance our mission to empower scientists with the most innovative tools to catalyze discovery.”
 
“I’m excited to drive the commercialization of Element’s current AVITI success and planned innovation capabilities to labs across the world,” said Van Oene. “I have seen firsthand how the industry is rapidly evolving to meet the needs of scientists, and I look forward to helping enable the future of biology.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters